AKS Khan Unveils Expansion with $12.5 Million Investment to Transform Bangladesh's Healthcare Landscape

The Investment Fund for Developing Countries (IFU) and AKS Khan Holdings are marking a significant milestone with IFU's investment of USD 12.5 million into AKS Khan Pharmaceuticals (AKPL), a leading pharmacy chain in Bangladesh. This capital injection aims to expand AKPL's presence nationwide, increasing access to quality healthcare services in Bangladesh by establishing 80 new pharmacy locations and 30 diagnostics centers. The primary aim is to benefit eight million patients annually by improving healthcare delivery, particularly in underserved regions, and offering quality diagnostics and medicines. This initiative is seen as a commitment to both the economic and social development of Bangladesh, enhancing healthcare accessibility throughout the nation. The project aligns with IFU's broader strategy to drive meaningful impact through healthcare investments, as well as fostering economic growth and social advancement in Bangladesh, underscoring Denmark's investment interest in the region. The expansion is expected to generate jobs, wealth, and contribute to the local economy while ensuring the delivery of authentic, affordable medicines across the country. The CEO of IFU, Lars Bo Bertram, emphasizes this project as a model of impactful investment and AKPL's founder, Samanzar Khan, expresses aspirations to develop a robust healthcare infrastructure capable of reaching all demographics within Bangladesh.